Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-10

FDA Approved: BRINEURA — Supplemental Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

FDA approved BioMarin's supplemental application for BRINEURA (cerliponase alfa), updating the approved labeling for the product. This reflects a regulatory mod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRINEURA (cerliponase alfa)

Snippet

SUPPL AP for BRINEURA (CERLIPONASE ALFA)